Qutenza

Product manufactured by Averitas Pharma Inc

Application Nr Approved Date Route Status External Links
NDA022395 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Qutenza Is Indicated For The Management Of Neuropathic Pain Associated With Postherpetic Neuralgia. • Qutenza Is A Trpv1 Channel Agonist Indicated For The Management Of Neuropathic Pain Associated With Postherpetic Neuralgia (Phn). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Capsaicin

Comments